High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma : The Seattle experience
β Scribed by Ajay K. Gopal; Tracee L. Metcalfe; Ted A. Gooley; John M. Pagel; Stephen H. Petersdorf; William I. Bensinger; Leona Holmberg; David G. Maloney; Oliver W. Press
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 135 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by highβdose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre
## Abstract The role of involved field radiation therapy (IFβRT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for nonβHodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IFβRT. A
## Abstract ## BACKGROUND Neurolymphomatosis (NL) is a rare neurologic manifestation of systemic lymphoma characterized by lymphomatous infiltration of the peripheral nervous system. The diagnosis of NL is difficult and requires a multidisciplinary approach for obtaining an adequate biopsy specime